Serum HMGB1 as a biomarker and predictive model for pediatric septic shock: a cohort study

Serum HMGB1, particularly when combined with PCT in a nomogram model, demonstrates excellent prognostic accuracy for early identification of septic shock risk in pediatric sepsis. This practical bedside tool may facilitate timely risk stratification and guide clinical decision-making, though external validation is needed.